Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rutgers

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 27, 2017
Additional value of <sup>18</sup>F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancerMette S van Ramshorst, Suzana C Teixeira, Bas B Koolen, et al.
Annals of Surgical Oncology|May 12, 2021
Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center ExperienceMarieke E M van der Noordaa, Ileana Ioan, Emiel J Rutgers, et al.
Cancer|February 19, 1999
Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST)A C Voogd, G van Tienhoven, H L Peterse, et al.
Diagnostic Pathology|August 22, 2021
Interobserver variability between experienced and inexperienced observers in the histopathological analysis of Wilms tumors: a pilot study for future algorithmic approachJikke J Rutgers, Tessa Bánki, Ananda van der Kamp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
Development of the first prediction model for radiation-induced contrast enhancement after proton therapy for posterior fossa tumours in paediatric patientsAbel Bregman, Jikke J Rutgers, Truls Andersen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2025
Imaging changes with or without neurological symptoms after proton therapy in pediatric posterior fossa tumors; initial experience of the Dutch national cohortJikke J Rutgers, John H Maduro, Peter S N van Rossum, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2022
Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancerSonja B Vliek, Florentine S Hilbers, Agnes Jager, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2015
First results of the preoperative accelerated partial breast irradiation (PAPBI) trialFemke van der Leij, Sophie C J Bosma, Marc J van de Vijver, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2018
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)A G J van Rossum, M Kok, E van Werkhoven, et al.
Annals of Surgery|May 5, 2018
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer PatientsAlexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 27, 2017
Additional value of <sup>18</sup>F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancerMette S van Ramshorst, Suzana C Teixeira, Bas B Koolen, et al.
Annals of Surgical Oncology|May 12, 2021
Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center ExperienceMarieke E M van der Noordaa, Ileana Ioan, Emiel J Rutgers, et al.
Cancer|February 19, 1999
Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST)A C Voogd, G van Tienhoven, H L Peterse, et al.
Diagnostic Pathology|August 22, 2021
Interobserver variability between experienced and inexperienced observers in the histopathological analysis of Wilms tumors: a pilot study for future algorithmic approachJikke J Rutgers, Tessa Bánki, Ananda van der Kamp, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
Development of the first prediction model for radiation-induced contrast enhancement after proton therapy for posterior fossa tumours in paediatric patientsAbel Bregman, Jikke J Rutgers, Truls Andersen, et al.
International Journal of Radiation Oncology, Biology, Physics|September 2, 2025
Imaging changes with or without neurological symptoms after proton therapy in pediatric posterior fossa tumors; initial experience of the Dutch national cohortJikke J Rutgers, John H Maduro, Peter S N van Rossum, et al.
European Journal of Cancer (Oxford, England : 1990)|September 20, 2022
Ten-year follow-up of the observational RASTER study, prospective evaluation of the 70-gene signature in ER-positive, HER2-negative, node-negative, early breast cancerSonja B Vliek, Florentine S Hilbers, Agnes Jager, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2015
First results of the preoperative accelerated partial breast irradiation (PAPBI) trialFemke van der Leij, Sophie C J Bosma, Marc J van de Vijver, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2018
Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04)A G J van Rossum, M Kok, E van Werkhoven, et al.
Annals of Surgery|May 5, 2018
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer PatientsAlexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, et al.
Pageof 18